Citadel Advisors’s Predictive Oncology POAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,737
| Closed | -$13.2K | – | 6482 |
|
|
2024
Q2 | $13.2K | Buy |
+12,737
| New | +$13.2K | ﹤0.01% | 5478 |
|
|
2023
Q1 | – | Sell |
-4,398
| Closed | -$27K | – | 6399 |
|
|
2022
Q4 | $27K | Sell |
4,398
-4,593
| -51% | -$28.2K | ﹤0.01% | 5479 |
|
|
2022
Q3 | $65K | Buy |
+8,991
| New | +$65K | ﹤0.01% | 5232 |
|
|
2021
Q3 | – | Sell |
-5,866
| Closed | -$154K | – | 6927 |
|
|
2021
Q2 | $154K | Buy |
+5,866
| New | +$154K | ﹤0.01% | 5740 |
|
|
2020
Q4 | – | Sell |
-1,569
| Closed | -$26K | – | 5468 |
|
|
2020
Q3 | $26K | Buy |
1,569
+687
| +78% | +$11.4K | ﹤0.01% | 4501 |
|
|
2020
Q2 | $29K | Buy |
+882
| New | +$29K | ﹤0.01% | 4450 |
|
|
2019
Q4 | – | Sell |
-113
| Closed | -$11K | – | 4997 |
|
|
2019
Q3 | $11K | Buy |
+113
| New | +$11K | ﹤0.01% | 4577 |
|
|
2019
Q2 | – | Sell |
-58
| Closed | -$9K | – | 4987 |
|
|
2019
Q1 | $9K | Hold |
58
| – | – | ﹤0.01% | 4459 |
|
|
2018
Q4 | $7K | Sell |
58
-50
| -46% | -$6.03K | ﹤0.01% | 4431 |
|
|
2018
Q3 | $23K | Buy |
+108
| New | +$23K | ﹤0.01% | 4120 |
|
|
2018
Q2 | – | Sell |
-95
| Closed | -$21K | – | 4483 |
|
|
2018
Q1 | $21K | Sell |
95
-21
| -18% | -$4.64K | ﹤0.01% | 3865 |
|
|
2017
Q4 | $24K | Buy |
+116
| New | +$24K | ﹤0.01% | 3748 |
|
|
2017
Q3 | – | Sell |
-165
| Closed | -$48K | – | 4000 |
|
|
2017
Q2 | $48K | Buy |
+165
| New | +$48K | ﹤0.01% | 3396 |
|
|
2017
Q1 | – | Sell |
-55
| Closed | -$31K | – | 4050 |
|
|
2016
Q4 | $31K | Buy |
55
+16
| +41% | +$9.02K | ﹤0.01% | 3381 |
|
|
2016
Q3 | $32K | Buy |
+39
| New | +$32K | ﹤0.01% | 3350 |
|
|
2016
Q2 | – | Sell |
-6
| Closed | -$5K | – | 3765 |
|
|
2016
Q1 | $5K | Buy |
+6
| New | +$5K | ﹤0.01% | 3273 |
|